Bristol-Myers Squibb Co (BUE:BMY) Current Accrued Expense : ARS550,075 Mil (As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is Bristol-Myers Squibb Co Current Accrued Expense?

Bristol-Myers Squibb Co's Current Accrued Expense for the quarter that ended in Mar. 2025 was ARS550,075 Mil.

Bristol-Myers Squibb Co's quarterly Current Accrued Expense increased from Sep. 2024 (ARS486,656 Mil) to Dec. 2024 (ARS577,720 Mil) but then declined from Dec. 2024 (ARS577,720 Mil) to Mar. 2025 (ARS550,075 Mil).

Bristol-Myers Squibb Co's annual Current Accrued Expense increased from Dec. 2022 (ARS53,816 Mil) to Dec. 2023 (ARS125,989 Mil) and increased from Dec. 2023 (ARS125,989 Mil) to Dec. 2024 (ARS577,720 Mil).

Bristol-Myers Squibb Co Current Accrued Expense Historical Data

The historical data trend for Bristol-Myers Squibb Co's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Current Accrued Expense Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Current Accrued Expense

Get a 7-Day Free Trial

35,318.92

38,174.22

53,815.65

125,989.00

577,720.01

Bristol-Myers Squibb Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Current Accrued Expense	Get a 7-Day Free Trial															460,005.01	529,240.49	486,655.98	577,720.01	550,075.06

Bristol-Myers Squibb Co Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Bristol-Myers Squibb Co Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (BUE:BMY) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BMYB34:Brazil BMYS:Austria

Address

Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.